| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/30/2007 | US20070202013 Masked Solid Supports |
| 08/30/2007 | US20070202012 electrical and electronic apparatus comprising electronic excitation device that provides an excitation voltage to sensors, analog-to-digital signal conversion devices that convert the resistances of the sensors to digital signals and means for calculating gas concentrations from the digital signals |
| 08/30/2007 | US20070202011 Automatic analyzing apparatus |
| 08/30/2007 | US20070202007 Test element analysis system with contact surfaces coated with hard material |
| 08/30/2007 | US20070201951 System for measuring material properties from a moving construction vehicle |
| 08/30/2007 | US20070201787 Sensor device |
| 08/30/2007 | US20070200058 Fluorescent phantom device |
| 08/30/2007 | US20070199901 Method And Device For Division Of A Biological Sample By Magnetic Effect |
| 08/30/2007 | US20070199818 Biosensors and Methods of Making |
| 08/30/2007 | US20070199513 Diagnostic litter for animals |
| 08/30/2007 | US20070199368 Apparatus and Method for Testing Reservoir Drilling Fluids for Drilling Unconsolidated Tar Sands |
| 08/30/2007 | US20070199366 Gas sensor unit and sensor cap |
| 08/30/2007 | DE19821903B4 Blutanalysesystem zum Verfahren zum Steuern eines Blutanalysesystems A system for blood analysis method for controlling a blood analysis system |
| 08/30/2007 | DE10312115B4 Applikator zur Aufnahme von Teststreifen Applicator for receiving test strips |
| 08/30/2007 | DE102006027760A1 Neue Melamin-Formaldehyd-Kondensationsprodukte mit thermoplastischen Eigenschaften New melamine-formaldehyde condensation products with thermoplastic properties |
| 08/30/2007 | DE102006017153B3 Surface structures producing method for molecular diagnostics in medicine, involves applying metallic coating on regions and depositing scavenger molecules on metallic coating of regions over bonding mechanism |
| 08/30/2007 | DE102006009534A1 Method for preserving somatostatin in samples of body fluid, particularly for subsequent quantitative analysis, by applying and binding the sample to a carrier |
| 08/30/2007 | DE102006009516A1 Test device for detecting an analyte in a liquid sample comprises a dry porous support with a reaction zone containing an analyte-selective binder, a biomarker/reporter enzyme complex and a reporter substrate |
| 08/30/2007 | DE102006008869A1 Material`s e.g. lacquer, high-throughput test implementing method for coating surface of substrate, involves coating substrate surface with respective materials below respective surface coatings that are hardened by ultraviolet-light |
| 08/30/2007 | DE102006007342A1 Documentation method for veterinary medicinal surveys, involves detecting coding of sample container by reading device, and transmitting coding to spatially separate output unit for production of reference coding as data record |
| 08/30/2007 | DE102006007315A1 Probensammelverfahren und Probensammeleinrichtung Sample collection methods and sample collection device |
| 08/30/2007 | CA2659773A1 Methods and compositions for analyte detection |
| 08/30/2007 | CA2643993A1 Methods and arrays for target analyte detection and determination of target analyte concentration in solution |
| 08/30/2007 | CA2643603A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 08/30/2007 | CA2643565A1 Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
| 08/30/2007 | CA2643561A1 Cancerous disease modifying antibody 141205-05 |
| 08/30/2007 | CA2643555A1 Cytotoxicity mediation of cells evidencing surface expression of cd59 |
| 08/30/2007 | CA2643370A1 Fluid transfer mechanism |
| 08/30/2007 | CA2643168A1 Apparatus for measuring fluorescent material in a liquid |
| 08/30/2007 | CA2643144A1 Cancerous disease modifying antibody 141205-04 |
| 08/30/2007 | CA2643063A1 Cancerous disease modifying antibody 141205-02 |
| 08/30/2007 | CA2643060A1 Analysis of thin liquid films |
| 08/30/2007 | CA2643059A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 08/30/2007 | CA2643042A1 Presentation of recognition motifs by a multivalent matrix grafted onto a solid support |
| 08/30/2007 | CA2642833A1 Free ngal as a biomarker for cancer |
| 08/30/2007 | CA2642518A1 In-line quadrature and anti-reflection enhanced phase quadrature interferometric detection |
| 08/30/2007 | CA2641915A1 A system for detecting one or more predetermined optically derivable characteristics of a sample |
| 08/30/2007 | CA2641360A1 Separation-free assay method |
| 08/30/2007 | CA2640324A1 Infectivity assay |
| 08/30/2007 | CA2638762A1 Ammonia transporter gene and use thereof |
| 08/30/2007 | CA2636449A1 Vascular tumor markers |
| 08/29/2007 | EP1826570A1 Reagent containing oxygen isotope-labeled hemoglobin for examining vital tissue and method of producing the same |
| 08/29/2007 | EP1826569A1 Identifying material from a breast duct |
| 08/29/2007 | EP1826568A1 Method for judging feature of malignant tumor |
| 08/29/2007 | EP1826567A1 Drug for diagnosing colon cancer and/or colon polyp, observing postoperative course and monitoring reoccurrence |
| 08/29/2007 | EP1826566A1 Immunochromatographic test device |
| 08/29/2007 | EP1826565A1 Biosensor and method for immobilizing a physiologically active substance |
| 08/29/2007 | EP1826564A1 A method for producing a biosensor |
| 08/29/2007 | EP1826563A1 Biosensor |
| 08/29/2007 | EP1826562A1 Method of pretreating specimen and immunoassay method using the same |
| 08/29/2007 | EP1826561A1 A substrate, a method for quantification of a target substance |
| 08/29/2007 | EP1826560A2 Methods for introducing heterologous cells into fish |
| 08/29/2007 | EP1826268A1 Ccr6- deficient mice or cells and modulation of inflammatory diseases |
| 08/29/2007 | EP1826218A1 Antihuman baff antibody |
| 08/29/2007 | EP1826217A1 Method for identification of antigenic peptides |
| 08/29/2007 | EP1825807A2 Implantable medical device with impedance measuring circuit |
| 08/29/2007 | EP1825806A2 Usability methods of wirelessly calibrating an analyte measurement meter and corresponding system |
| 08/29/2007 | EP1825275A2 Diagnosis of neurodegenerative diseases |
| 08/29/2007 | EP1825274A2 Diagnosis of neurodegenerative diseases |
| 08/29/2007 | EP1825273A1 Particle based binding assay |
| 08/29/2007 | EP1825272A2 Fungal signalling and metabolic enzymes |
| 08/29/2007 | EP1825271A2 Use of a serum/glucocorticoid-regulated kinase |
| 08/29/2007 | EP1825270A2 Chromatographic analyse-devices and test kits |
| 08/29/2007 | EP1825269A2 Surface enhanced raman spectroscopy using shaped gold nanoparticles |
| 08/29/2007 | EP1825268A2 Colorimetric sensors constructed of diacetylene materials |
| 08/29/2007 | EP1825267A2 Prticle-based multiplex assay for identifying glycosylation |
| 08/29/2007 | EP1825266A1 Sample-efficient lateral flow immunoassay |
| 08/29/2007 | EP1825265A2 Serum amyloid a protein in inflammation and obesity |
| 08/29/2007 | EP1825263A2 Cellular signaling pathway based assays, reagents and kits |
| 08/29/2007 | EP1825262A1 Delta-9-tetrahydrocannabinol detection method |
| 08/29/2007 | EP1825261A2 Diagnosis of conditions associated with decreased arginine bioavailability |
| 08/29/2007 | EP1825260A1 Assay method |
| 08/29/2007 | EP1825259A1 Aging biomarker |
| 08/29/2007 | EP1825258A1 Assays for superantigens |
| 08/29/2007 | EP1825257A2 Diagnostic system for determining substance concentrations in liquid samples |
| 08/29/2007 | EP1825256A2 Test medium for the rapid analysis of motor oils in internal combustion engines |
| 08/29/2007 | EP1825255A1 Solution for calibrating a chemical analyzer for alcohol, carbonate and ammonia assays |
| 08/29/2007 | EP1825254A2 Method for optimizing thiopurine efficacy and toxicity using mass spectrometry |
| 08/29/2007 | EP1825253A2 Blood type method system and device |
| 08/29/2007 | EP1825251A1 Method for analyzing lipoproteins |
| 08/29/2007 | EP1825249A2 Microwave accelerated assays |
| 08/29/2007 | EP1825006A2 Sensing phage-triggered ion cascade (septic) |
| 08/29/2007 | EP1825005A2 Mer diagnostic and therapeutic agents |
| 08/29/2007 | EP1825003A2 Identification and use of prognostic and predictive markers in cancer treatment |
| 08/29/2007 | EP1824993A1 Method of diagnosing cancer and reagents therefor |
| 08/29/2007 | EP1824992A1 Enzymatic measurement of imatinib mesylate |
| 08/29/2007 | EP1824991A2 Device and method for detection of analytes |
| 08/29/2007 | EP1824979A2 Methods, products and uses involving platelets and/or the vasculature |
| 08/29/2007 | EP1824978A1 Hcv f protein and uses thereof |
| 08/29/2007 | EP1824881A1 Tgr3-like protein receptor |
| 08/29/2007 | EP1824880A1 Soluble hla-e molecules and their use for diagnosing and treating pathologies |
| 08/29/2007 | EP1824878A1 Tnf antagonists |
| 08/29/2007 | EP1824796A2 Protein scaffolds and uses thereof |
| 08/29/2007 | EP1824586A1 Method for coating membranes |
| 08/29/2007 | EP1824564A2 Method for treating glioma |
| 08/29/2007 | EP1824520A2 Methods of detecting prostate cancer |
| 08/29/2007 | EP1824340A1 Method of using extracts of epimedium species |
| 08/29/2007 | EP1824336A2 Inhibition of hsp27 phosphorylation for treatment of blistering disorders |
| 08/29/2007 | EP1735457A4 METHODS FOR DETECTING Lp-PLA2 ACTIVITY AND INHIBITION OF Lp-PLA2 ACTIVITY |
| 08/29/2007 | EP1697746A4 Risk markers for cardiovascular disease |